Key Events This Week
4 May: Intraday high surge to Rs.797.35 (+7.25%)
5 May: Strong price rally closing at Rs.805.70 (+8.26%)
6 May: Partial recovery to Rs.788.50 (+2.15%)
7 May: Decline to Rs.776.60 (-1.51%)
8 May: Week closes at Rs.766.80 (-1.26%)

Aarti Pharmalabs Ltd is Rated Sell
2026-05-08 10:10:44Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, returns, and overall outlook.
Read full news article
Aarti Pharmalabs Ltd Sees Technical Momentum Shift Amid Strong Price Rally
2026-05-05 08:08:04Aarti Pharmalabs Ltd has exhibited a notable shift in price momentum, moving from a mildly bearish technical trend to a sideways stance, supported by a blend of bullish and bearish signals across key indicators. The stock’s recent surge of 8.26% in a single day to ₹805.70 reflects renewed investor interest, yet technical analysis reveals a complex picture that demands careful scrutiny.
Read full news article
Aarti Pharmalabs Ltd Surges 7.25% to Day's High of Rs 797.35 — Outperforms Sector by 6.42 Percentage Points
2026-05-04 14:16:03The Sensex gained a modest 0.44% on 4 May 2026, while Aarti Pharmalabs Ltd surged 7.25%, outperforming its Pharmaceuticals & Biotechnology sector by 6.42 percentage points. This sharp single-session advance stands out as a distinctly stock-specific event amid a broadly steady market backdrop.
Read full news article
Aarti Pharmalabs Ltd is Rated Sell
2026-04-27 10:11:18Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news article







